Dennis Slamon
Director, BioMarin Pharmaceutical.
Companies
- BioMarin PharmaceuticalBoard member Mar 21, 2014 to Mar 20, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioMarin Pharmaceutical BMRN31,299 shares2$1.7M at $54.75Mar 18, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 18, 2024Shares withheld for tax 9,510 shares at $83.81 of BioMarin Pharmaceutical2
- Mar 18, 2024Exercised options 10,000 shares at $79.70 of BioMarin Pharmaceutical2
- May 23, 2023Granted 4,190 shares of BioMarin Pharmaceutical3
- May 24, 2022Granted 4,980 shares of BioMarin Pharmaceutical4
- Feb 28, 2022Sold 100 shares at $78.37 of BioMarin Pharmaceutical5
- Feb 28, 2022Sold 122 shares at $78.36 of BioMarin Pharmaceutical5
- Feb 28, 2022Sold 100 shares at $78.35 of BioMarin Pharmaceutical5
- Feb 28, 2022Sold 214 shares at $78.35 of BioMarin Pharmaceutical5
- Feb 28, 2022Sold 45 shares at $78.34 of BioMarin Pharmaceutical5
- Feb 28, 2022Sold 5,815 shares at $78.33 of BioMarin Pharmaceutical5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 24, 2023
- 4SEC EDGARForm 4 filed May 26, 2022
- 5SEC EDGARForm 4 filed Mar 2, 2022